By route of administration, the parenteral segment contributed the highest market share of approximately 88% in 2025
The female mice (homozygous for Hba tm1(HBA)Tow and heterozygous for Hbb tm2(HBG1,HBB*)Tow and Hbb tm3(HBG1,HBB)Tow [h/h:: A / S ], sickle-cell trait mice) and male mice (homozygous for both Hba tm1(HBA)Tow and Hbb tm2(HBG1,HBB*)Tow [h/h:: S / S ], sickle SCD mice) were bred to generate SCD mice
Clinical data on this specific combination is limited, but the pharmacological rationale is sound
Compatibility With Other Treatments/Drugs Avoid concurrent use with exogenous growth hormone therapy (Sermorelin)
OMahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF
The secretion of endogenous human growth hormone is associated with benefits such as bone formation, enhanced tissue repair, and improved cognitive function